Entera Bio Ltd. SEC filings ENTX

Entera Bio Ltd. has 418 filings in SEC EDGAR's recent list, going back to May 1, 2015. Its latest annual report, Form ARS, was filed on Jun 3, 2026 for the period ended Jun 3, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Jun 3, 2026 Jun 3, 2026
10-K Annual report Mar 27, 2026 Dec 31, 2025
ARS Annual report to shareholders Jun 5, 2025 May 29, 2025
10-K Annual report Mar 28, 2025 Dec 31, 2024
ARS Annual report to shareholders Jun 20, 2024 Jun 20, 2024
10-K Annual report Mar 8, 2024 Dec 31, 2023
ARS Annual report to shareholders Aug 16, 2023 Aug 15, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
10-K/A Amended annual report Apr 29, 2022 Dec 31, 2021
10-K Annual report Mar 8, 2022 Dec 31, 2021
20-F Annual report (foreign issuer) Mar 18, 2021 Dec 31, 2020
20-F Annual report (foreign issuer) Mar 26, 2020 Dec 31, 2019
20-F/A Amended annual report (foreign issuer) Apr 17, 2019 Dec 31, 2018
20-F Annual report (foreign issuer) Mar 28, 2019 Dec 31, 2018

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
ENTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Jerusalem
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1638097

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.